Please provide your email address to receive an email when new articles are posted on . Yttrium-90 is a beta-emitting isotope with high-energy radiation that travels an average of 2.5 mm and a maximum ...

Children’s Healthcare of Atlanta is one of the first pediatric centers to offer Y90 Radioembolization treatment to pediatric patients with liver cancer. The system recently completed treatment on its ...

Pattern of failure after hepatic arterial concurrent chemoradiotherapy for locally advanced hepatocellular carcinoma. Background: There are limited modalities in the treatment of inoperable liver NET ...

A randomized cross-over trial comparing single-agents capecitabine (C) and UFT plus leucovorin (LV) in patients (Pts) with advanced colorectal cancer (CRC): Preliminary data of a patient preference ...

Hackensack Meridian Health Bayshore Medical Center now offers Y-90 radioembolization, an advanced and minimally invasive method to treat liver tumors without surgery. This procedure is used to treat ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...

Aspirin usage has been under scrutiny in recent research. But now, studies are bringing aspirin therapy in renewed light with its association in improving liver function after an embolization ...

Aspirin therapy is associated with both improved liver function test results and survival after transarterial embolization for hepatocellular carcinoma, according to a new article. Aspirin therapy is ...

Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...